H&R GmbH KGaA (LTS:0RRC) Total Liabilities: €515 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RRC H&R GmbH & Co KGaA LTS:0RRC
65 GF Score
Price €6.44
GF Value €4.10
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is H&R GmbH KGaA Total Liabilities?

H&R GmbH KGaA LTS:0RRC 65 Total Liabilities is €515 Mil as of Mar. 2026. GuruFocus rates LTS:0RRC with a GF Score™ of 65/100 and a GF Value™ of €4.10 (Significantly Overvalued). The stock has 6 warning signs investors should review.

H&R GmbH KGaA's Total Liabilities for the quarter that ended in Mar. 2026 was €515 Mil.

H&R GmbH KGaA's quarterly Total Liabilities declined from Sep. 2025 (€531.54 Mil) to Dec. 2025 (€500.11 Mil) but then increased from Dec. 2025 (€500.11 Mil) to Mar. 2026 (€515.48 Mil).

H&R GmbH KGaA's annual Total Liabilities increased from Dec. 2023 (€453.17 Mil) to Dec. 2024 (€554.27 Mil) but then declined from Dec. 2024 (€554.27 Mil) to Dec. 2025 (€500.11 Mil).

H&R GmbH KGaA Total Liabilities Historical Data

* Premium members only.

The historical data trend for H&R GmbH KGaA's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H&R GmbH KGaA Total Liabilities Chart

H&R GmbH KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 465.91 490.91 453.17 554.27 500.11

H&R GmbH KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 545.42 522.03 531.54 500.11 515.48
LTS:0RRC
65GF Score
H&R GmbH & Co KGaA LTS:0RRC
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H&R GmbH KGaA Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

H&R GmbH KGaA's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=304.524+(48.299+89.414
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+57.871+0)
=500

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=916.189-416.081
=500

H&R GmbH KGaA's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=320.803+(17.433+123.981
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+53.258+0)
=515

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=943.439-427.964
=515

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €515 Mil mean?
H&R GmbH KGaA (LTS:0RRC) has a Total Liabilities of €515 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for H&R GmbH KGaA and its competitors.
Is H&R GmbH KGaA's Total Liabilities too high?
H&R GmbH KGaA's current Total Liabilities is €515 Mil. Overall, H&R GmbH KGaA has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's Total Liabilities compare to LIN and SHW?
H&R GmbH KGaA's Total Liabilities of €515 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Chemicals company?
A good Total Liabilities depends on the Chemicals industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for H&R GmbH KGaA and its competitors. H&R GmbH KGaA's current Total Liabilities is €515 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (LTS:0RRC) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.10, compared to a current price of €6.44 — trading 57.1% above its estimated fair value. The current Total Liabilities is €515 Mil. H&R GmbH KGaA's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For H&R GmbH KGaA (LTS:0RRC), the current Total Liabilities is €515 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H&R GmbH KGaA (LTS:0RRC) Overvalued in 2026?

Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued. The current stock price of €6.44 is trading 57.1% above its estimated GF Value™ of €4.10. GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.

Key valuation signals for LTS:0RRC:

  • Total Liabilities: €515 Mil
  • GF Value™: €4.10 vs. price of €6.44 (57.1% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the LTS:0RRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

H&R GmbH KGaA Business Description

Other Exchanges 2HRA:Germany2HRA:Austria
Address Neuenkirchener Strasse 8, Salzbergen, NI, DEU, 48499
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
65GF Score

Get the complete analysis for LTS:0RRC

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.44
Price
€4.10
GF Value